“Micro-introducer access” intra-arterial chemotherapy for retinoblastoma in an 8-week-old infant
Intra-arterial chemotherapy (IAC) for retinoblastoma has emerged as a standard therapy to facilitate globe salvage in patients with retinoblastoma. However, transfemoral endovascular catheterization of the ophthalmic artery is typically reserved for infants aged 3 months or older due to size of the...
Main Authors: | Carlos M. Alvarez, Samir Sur, Brian M. Snelling, Robert M. Starke, Eric C. Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Interdisciplinary Neurosurgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214751918303037 |
Similar Items
-
Update on Intra-Arterial Chemotherapy for Retinoblastoma
by: Mario Zanaty, et al.
Published: (2014-01-01) -
Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.
by: Y Pierre Gobin, et al.
Published: (2012-01-01) -
Intra-arterial chemotherapy for retinoblastoma
by: Jorge Balderrama, et al.
Published: (2013-12-01) -
Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma
by: Saerom Choi, et al.
Published: (2013-06-01) -
Comment: Intra-arterial chemotherapy for retinoblastoma
by: Savleen Kaur, et al.
Published: (2017-01-01)